CAR T in myeloma is a personalized, living therapy, timing and eligibility matter, preparation is key and lasting responses are possible. @DrKrinaPatel of MDACC at the HealthTree Houston Roundtable. #mmsm

Patients can ask their doctor about CAR T eligibility. Am I a candidate? Do I need a referral to a CAR T center? Are there CAR T trials I should join? @DrKrinaPatel of MDACC at the HealthTree Houston Roundtable. #mmsm

Individualizing therapy in myeloma factors in genetics, frailty and comorbidities, patient outcomes, adapted treatment based on MRD status, toxicity, disease resistance, social factors and sequencing. Savari Yellqpragada, MD of MDACC. #mmsm

Frailty rather than age predicts outcomes in myeloma - Sarvari Yellqpragada, MD of MDACC at the Houston HealthTree Roundtable. Frail patients can limit induction, avoid transplant and de-escalate maintenance. #mmsm

“Assessing risk can be risky” says Bill Matsui, MD of MDACC. It’s statistical, not exact. Risk can change over time and each risk factor (genetics, disease stage, etc) may contribute differently for each myeloma patient. At the HealthTree Houston Roundtable #mmsm

Bill Matsui, MD of MD Anderson shares early precursor conditions and how newly diagnosed myeloma patients can find personalized care - today at the Houston HealthTree Roundtable. #mmsm

Join Dr. William G. Wierda, MD, PhD from MD Anderson for a live CLL CME on Nov. 17, 5–6 PM CT. Explore treatment strategies and shared decision-making for personalized care. activities.paradigmmc.com/14… @ParadigmMedCom @CllSociety #CME

Better data can drive better care and research. HealthTree’s Personal Health Record brings patient health information together to support personalized care and, with patient consent, advance research. htree.org/personalhealthreco… #HealthTree #PersonalHealthRecord

What does “cure” mean in multiple myeloma? At #IMS2026, Dr. Mohamad Mohty explains how newer therapies, sustained MRD negativity, imaging, and treatment-free remission are changing the conversation around cure. Watch the full conversation. youtu.be/AftPCq2jsdA #MultipleMyeloma #MyelomaResearch #HealthTree